Skip to content
The Longevity Archive
ER-100 in all countries

Legal status · Canada

Is ER-100 legal in Canada?

InvestigationalLongevityEvidence: Preliminary

No. ER-100 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.

ER-100 in Canada at a glance

ClassificationInvestigational, not approved
Health Canada approval statusNot approved by Health Canada; investigational
Evidence levelPreliminary (research strength: Preliminary)
ReviewedSep 2026

Classification and note come from the ER-100 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.

What this means

  • 01

    ER-100 is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What ER-100 is

The first partial cellular reprogramming therapy in humans: Life Biosciences dosed the first patient in June 2026, delivering three Yamanaka factors to retinal cells to reverse epigenetic age in glaucoma and optic neuropathy.

ER-100 uses a gene therapy to express OCT4, SOX2 and KLF4 in retinal ganglion cells, switched on by a course of oral doxycycline, with the goal of resetting the cells' epigenetic age without erasing their identity. The FDA cleared the IND in January 2026 and the Phase 1 in glaucoma and non-arteritic anterior ischemic optic neuropathy began dosing in June.

Mechanism: Transient, inducible expression of three reprogramming factors (OSK) to restore youthful epigenetic patterns in aged cells.

Regulatory history: Investigational; Phase 1

How Health Canada treats this kind of product

Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.

The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for ER-100 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

ER-100 in other countries

Frequently asked questions

Is ER-100 legal in Canada?

No. ER-100 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.

Can I buy ER-100 in Canada?

No approved product exists to buy. In Canada ER-100 is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is ER-100 Health Canada approved?

No. In Canada ER-100 is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Investigational; Phase 1. Evidence level: Preliminary.

Related compounds in Canada

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for ER-100 live on its compound profile.

ER-100 profile

This page is general information about the regulatory status of ER-100 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.